EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches

Reiko Inagi

Recent Patents on Cardiovascular Drug Discovery · 2006

DOI: 10.2174/157489006777442450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Cardiovascular Drug Discovery, 2006. Verfasst von Reiko Inagi. Beteiligte Einrichtung: Institute of Medical Sciences, Tokai University School of Medicine, Bohseidai, Isehara Kanagawa 259-1193, Japan. inagi@is.icc.u-tokai.ac.jp. Hauptthemen laut MEDLINE: Oxidative Stress. Die Arbeit wurde bisher 29-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is a common denominator in many aspects of the pathogenesis of atherosclerosis and cardiovascular diseases. Some drugs, such as vitamin C, vitamin E, and a free radical scavenger, edaravone, are prescribed with oxidative stress as their main target. Furthermore, of the drugs in current clinical use, such as anti-hypertension reagents including angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB), and anti-hyperlipidemic reagents like statins, protect various organs, e.g., vessel, brain, heart, and kidney, via anti-oxidative stress effects in addition to their original pharmacological properties. While results of clinical trials of anti-oxidative stress reagents in patients with cardiovascular disease are contradictory to date, this may be explained by a variety of reasons such as an inadequate study design. More competent anti-oxidative reagents are awaited, and superoxide dismutase mimetics, thiols, xanthine oxidase and NAD(P)H oxidase inhibitors, which regulate intracellular redox reaction and subsequently inhibit oxidative stress, are among promising candidates of future drug developments currently receiving much interest. In this review, the current advances will be highlighted in development of novel anti-oxidative therapeutic approaches against cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressAngiotensin-Converting Enzyme InhibitorsAnimalsAntioxidantsCardiovascular DiseasesFree Radical ScavengersHumansNADPH OxidasesNitric Oxide Donors

Substanzen

Angiotensin-Converting Enzyme InhibitorsAntioxidantsFree Radical ScavengersNitric Oxide DonorsNADPH Oxidases

Autor:innen und Institutionen

  • Institute of Medical Sciences, Tokai University School of Medicine, Bohseidai, Isehara Kanagawa 259-1193, Japan. inagi@is.icc.u-tokai.ac.jp

Zitieren

APA

Inagi, R. (2006). Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches. Recent Patents on Cardiovascular Drug Discovery. https://doi.org/10.2174/157489006777442450

Vancouver

Inagi R. Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches. Recent Patents on Cardiovascular Drug Discovery. 2006. doi:10.2174/157489006777442450

BibTeX
@article{Inagi2006,
  author = {Inagi, Reiko},
  title = {Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches},
  journal = {Recent Patents on Cardiovascular Drug Discovery},
  year = {2006},
  doi = {10.2174/157489006777442450}
}
Kostenlos starten →